PNPLA3 and metabolic dysfunction-associated steatohepatitis: Three risk alleles uncovered in genome-wide association studies on NASH patients include polymorphisms in the LD-associated genes HSD17B13 (114), PNPLA3 (115), and TM6SF2 (116).